Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: September 21, 2004
Last updated: May 21, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)